返回 Agenda
Session Chair(s)
Louise Déry
Director, Policy, Planning and International Affairs Directorate
Health Canada, Canada
Speaker(s)
Advancement in Clinical Research Investment and Future Innovation in Canada
Ed Dybka
Astrazeneca Canada, Inc., Canada
President
ICH Updates
Celia Lourenco, PHD
Health Canada, Canada
Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB
Update from the Australian Therapeutic Goods Administration (TGA)
Diane Wilkinson
Australian Therapeutic Goods Administration (TGA), Australia
Asst Dir, Regulatory Reform and Coordination Section, Complementary Medicines Br
Closing Remarks
Simon Kennedy, MS
Health Canada, Canada
Deputy Minister of Health